Markets

Top Ranked Momentum Stocks to Buy for October 31st

Here are four stocks with buy ranks and strong momentum characteristics for investors to consider today, October 31 st :

Acacia Communications, Inc. (ACIA): This provider of high-speed coherent interconnect products carries a Zacks Rank #1 (Strong Buy), as the Zacks Consensus Estimate for its current year earnings has advanced 6.1% over the last 30 days.

ACACIA COMMUNIC Price and Consensus

ACACIA COMMUNIC Price and Consensus | ACACIA COMMUNIC Quote

Acacia Communications' year-to-date return is a whopping 130.2%. The company possess a Momentum Score of A.

ACACIA COMMUNIC Price

ACACIA COMMUNIC Price | ACACIA COMMUNIC Quote

Allison Transmission Holdings, Inc. (ALSN): This manufacturer of commercial and defense fully-automatic transmissions for medium- and heavy-duty commercial vehicles has seen the Zacks Consensus Estimate for its current year earnings soaring 5.1% over the last 30 days. As a result, it holds a Zacks Rank #1.

ALLISON TRANSMN Price and Consensus

ALLISON TRANSMN Price and Consensus | ALLISON TRANSMN Quote

Allison Transmission's year-to-date return is 13.3%. The company possess a Momentum Score of B.

ALLISON TRANSMN Price

ALLISON TRANSMN Price | ALLISON TRANSMN Quote

Arch Capital Group Ltd. (ACGL): This provider of property, casualty, and mortgage insurance and reinsurance products has seen the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 30 days. As a result, it carries a Zacks Rank #2 (Buy).

ARCH CAP GP LTD Price and Consensus

ARCH CAP GP LTD Price and Consensus | ARCH CAP GP LTD Quote

Arch Capital's year-to-date return is 11.1%, compared with the S&P 500's return of 4.2%. The company possess a Momentum Score of A.

ARCH CAP GP LTD Price

ARCH CAP GP LTD Price | ARCH CAP GP LTD Quote

Ariad Pharmaceuticals Inc. (ARIA): this oncology company holds a Zacks Rank #2, as the Zacks Consensus Estimate for its current year earnings has surged 21.6% over the last 30 days.

ARIAD PHARMA Price and Consensus

ARIAD PHARMA Price and Consensus | ARIAD PHARMA Quote

Ariad Pharmaceuticals' year-to-date return is 40.5%. The company carries a Momentum Score of A.

ARIAD PHARMA Price

ARIAD PHARMA Price | ARIAD PHARMA Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here

Want to see all of today's Zacks Strong Buys?

You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 stocks free of charge. There is no better place to start your own stock search. Plus you can also access the full list of must-avoid Zacks Strong Sells and other private research. See the stocks free >> .

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ARIAD PHARMA (ARIA): Free Stock Analysis Report

ALLISON TRANSMN (ALSN): Free Stock Analysis Report

ACACIA COMMUNIC (ACIA): Free Stock Analysis Report

ARCH CAP GP LTD (ACGL): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ACGL ALSN ACIA

Other Topics

Investing Stocks

Latest Markets Videos